Guest post by Dr. Lucica Ditiu, Executive Secretary of the Stop TB Partnership
I keep asking myself and those around me, why, in the 21st Century, are 1.4 million people a year still dying from TB, when it is a curable disease?
With TB largely consigned to the history books in Europe and the US, why can we not put a stop to this disease globally? Why are so few of us outraged that women and children are dying from TB in the same way as characters from La Bohéme or Les Misérables?
I also ask why we have not had any significant breakthroughs in TB research and development science and research, despite the disease being around for the last 2000 years? Why do we still have to use the 90 year-old Bacille Calmette–Guérin (BCG) vaccine and the same drugs that were developed 50 years ago?
One of the answers to these questions is that the global fight against TB is underfunded and has not benefited from significant attention for some time. Is it almost as if the human race has become complacent and gotten used to having TB around.
To make things worse, years of neglect in the provision of quality TB care and a lack of funding has led to the development of strains of TB that are resistant to the most commonly used anti-TB drugs. Known as multidrug-resistant TB and extensively drug-resistant TB, these strains can spread through the air like any other airborne disease.
I need to make one point clear. We should acknowledge what the TB community has achieved in the past 15 years with the tools, financing and support it has received from the global community. By rolling out quality TB care around the world we have saved 20 million lives since 1990. TB and HIV programmes are working much better together to address this double epidemic. The voices of people affected by TB have become louder in demanding access to quality services. A new rapid diagnosis test is being rolling out, a new anti-TB drug was announced in the first days of this year and more than a dozen TB vaccines are in the clinical trial phase.
However, we have a long and difficult way in front of us and this is the time for action! We cannot afford progress to grind to a halt. We must ensure that there is enough funding to provide TB care to all, especially the vulnerable and stigmatized, and ensure that we can find and treat the 3 million people a year who get ill with TB but don’t receive the quality care they need.
Therefore we need to ensure that the Global Fund—which provides the vast majority of international financing for TB programmes—has a successful fundraising drive this year.
We must also support countries and governments to mobilize domestic sources of funding so we can scale up our efforts and provide access to TB services for all that need them. We urgently need a steep increase in the financing for research and development for new tools—drugs, vaccines and diagnostics—if we are to achieve our dreams.
Dr. Lucica Ditiu was appointed Executive Secretary of the Stop TB Partnership in January 2011. A native of Romania, Dr. Ditiu is a physician and researcher who has devoted her career to improving the lives of people living in communities heavily burdened by tuberculosis (TB).
Recent Comments